 HIV Antigens
"HIV Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus (HIV); also called HTLV-III-associated and lymphadenopathy-associated virus (LAV) antigens.
| Descriptor ID |
D015488
|
| MeSH Number(s) |
D23.050.327.520
|
| Concept/Terms |
HIV Antigens- HIV Antigens
- Antigens, HIV
- AIDS Antigens
- Antigens, AIDS
- HIV Associated Antigens
- Antigens, HIV Associated
- Associated Antigens, HIV
- HIV-Associated Antigens
- Antigens, HIV-Associated
- HTLV III Antigens
- Antigens, HTLV III
- III Antigens, HTLV
- T Lymphotropic Virus Type III Antigens, Human
- HTLV III LAV Antigens
- HTLV-III-LAV Antigens
- Antigens, HTLV-III-LAV
- LAV Antigens
- Antigens, LAV
- Lymphadenopathy Associated Antigens
- Antigens, Lymphadenopathy Associated
- Associated Antigens, Lymphadenopathy
- Lymphadenopathy-Associated Antigens
- Antigens, Lymphadenopathy-Associated
- T-Lymphotropic Virus Type III Antigens, Human
- HTLV-III Antigens
- Antigens, HTLV-III
|
Below are MeSH descriptors whose meaning is more general than "HIV Antigens".
Below are MeSH descriptors whose meaning is more specific than "HIV Antigens".
This graph shows the total number of publications written about "HIV Antigens" by people in this website by year, and whether "HIV Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 | | 2001 | 0 | 1 | 1 | | 2004 | 1 | 0 | 1 | | 2005 | 1 | 0 | 1 | | 2006 | 1 | 0 | 1 | | 2015 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2018 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "HIV Antigens" by people in Profiles.
-
Zhang P, Gorman J, Geng H, Liu Q, Lin Y, Tsybovsky Y, Go EP, Dey B, Andine T, Kwon A, Patel M, Gururani D, Uddin F, Guzzo C, Cimbro R, Miao H, McKee K, Chuang GY, Martin L, Sironi F, Malnati MS, Desaire H, Berger EA, Mascola JR, Dolan MA, Kwong PD, Lusso P. Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer. Cell Host Microbe. 2018 06 13; 23(6):832-844.e6.
-
Wendel SK, Longosz AF, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Quinn TC, Laeyendecker O. Short Communication: The Impact of Viral Suppression and Viral Breakthrough on Limited-Antigen Avidity Assay Results in Individuals with Clade B HIV Infection. AIDS Res Hum Retroviruses. 2017 04; 33(4):325-327.
-
Jacobson JM, Zheng L, Wilson CC, Tebas P, Matining RM, Egan MA, Eldridge J, Landay AL, Clifford DB, Luetkemeyer AF, Tiu J, Martinez AL, Janik J, Spitz TA, Hural J, McElrath J, Frahm N. The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection. J Acquir Immune Defic Syndr. 2016 Feb 01; 71(2):163-71.
-
Neff CP, Chain JL, MaWhinney S, Martin AK, Linderman DJ, Flores SC, Campbell TB, Palmer BE, Fontenot AP. Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects. Am J Respir Crit Care Med. 2015 Feb 15; 191(4):464-73.
-
Fern?ndez G, Manzardo C, Montoliu A, Campbell C, Fern?ndez G, Casabona J, Mir? JM, Matas L, Rivaya B, Gonz?lez V. Evaluation of an antibody avidity index method for detecting recent human immunodeficiency virus type 1 infection using an automated chemiluminescence immunoassay. Enferm Infecc Microbiol Clin. 2015 Apr; 33(4):238-42.
-
Burgess ST, Kenyon F, O'Looney N, Ross AJ, Chong Kwan M, Beattie JS, Petrik J, Ghazal P, Campbell CJ. A multiplexed protein microarray for the simultaneous serodiagnosis of human immunodeficiency virus/hepatitis C virus infection and typing of whole blood. Anal Biochem. 2008 Nov 01; 382(1):9-15.
-
Koeppe JR, Campbell TB, Rapaport EL, Wilson CC. HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia. J Acquir Immune Defic Syndr. 2006 Feb 01; 41(2):140-8.
-
Wille-Reece U, Flynn BJ, Lor? K, Koup RA, Kedl RM, Mattapallil JJ, Weiss WR, Roederer M, Seder RA. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Proc Natl Acad Sci U S A. 2005 Oct 18; 102(42):15190-4.
-
McKinney DM, Skvoretz R, Livingston BD, Wilson CC, Anders M, Chesnut RW, Sette A, Essex M, Novitsky V, Newman MJ. Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL. J Immunol. 2004 Aug 01; 173(3):1941-50.
-
Connick E, Schlichtemeier RL, Purner MB, Schneider KM, Anderson DM, MaWhinney S, Campbell TB, Kuritzkes DR, Douglas JM, Judson FN, Schooley RT. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion. J Infect Dis. 2001 Dec 01; 184(11):1465-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|